Glioma–Immune Cell Crosstalk in Tumor Progression
Cancers · 11.01.2024 · 16 (2) · 308
DOI: 10.3390/cancers16020308 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 11.01.2024. Verfasst von Mahmoud Elguindy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, University of California, San Francisco, CA 94143, USA. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCI NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Glioma progression is a complex process controlled by molecular factors that coordinate the crosstalk between tumor cells and components of the tumor microenvironment (TME). Among these, immune cells play a critical role in cancer survival and progression. The complex interplay between cancer cells and the immune TME influences the outcome of immunotherapy and other anti-cancer therapies. Here, we present an updated view of the pro- and anti-tumor activities of the main myeloid and lymphocyte cell populations in the glioma TME. We review the underlying mechanisms involved in crosstalk between cancer cells and immune cells that enable gliomas to evade the immune system and co-opt these cells for tumor growth. Lastly, we discuss the current and experimental therapeutic options being developed to revert the immunosuppressive activity of the glioma TME. Knowledge of the complex interplay that elapses between tumor and immune cells may help develop new combination treatments able to overcome tumor immune evasion mechanisms and enhance response to immunotherapies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurological Surgery, University of California, San Francisco, CA 94143, USA.
ORCID-Profile: Winson S Ho
Förderung
- NIH HHS
- NCI NIH HHS
- NINDS NIH HHS
- Matthew Larson Pediatric Brain Tumor Foundation
- Meghan Rose Bradley Foundation
- US National Institutes of Health (NIH)
Zitieren
APA
Elguindy, M., Young, J. S., Mondal, I., Lu, R. O., & Ho, W. S. (2024). Glioma–Immune Cell Crosstalk in Tumor Progression. Cancers, 16(2), 308. https://doi.org/10.3390/cancers16020308
Vancouver
Elguindy M, Young JS, Mondal I, Lu RO, Ho WS. Glioma–Immune Cell Crosstalk in Tumor Progression. Cancers. 2024;16(2):308. doi:10.3390/cancers16020308
BibTeX
@article{Elguindy2024,
author = {Elguindy, Mahmoud and Young, Jacob S and Mondal, Isha and Lu, Rongze O and Ho, Winson S},
title = {Glioma–Immune Cell Crosstalk in Tumor Progression},
journal = {Cancers},
year = {2024},
volume = {16},
number = {2},
pages = {308},
doi = {10.3390/cancers16020308}
}
EUVIMED